Gilard V - Search Results

1

Interest of fluorine-19 nuclear magnetic resonance spectroscopy in the detection, identification and quantification of metabolites of anticancer and antifungal fluoropyrimidine drugs in human biofluids.

Martino R, Gilard V, Desmoulin F, Malet-Martino M. Martino R, et al. Among authors: gilard v. Chemotherapy. 2006;52(5):215-9. doi: 10.1159/000094744. Epub 2006 Jul 25. Chemotherapy. 2006. PMID: 16864998 Review.

2

A new approach to the study of ifosfamide metabolism by the analysis of human body fluids with 31P nuclear magnetic resonance spectroscopy.

Martino R, Crasnier F, Chouini-Lalanne N, Gilard V, Niemeyer U, De Forni M, Malet-Martino MC. Martino R, et al. Among authors: gilard v. J Pharmacol Exp Ther. 1992 Mar;260(3):1133-44. J Pharmacol Exp Ther. 1992. PMID: 1545382

3

Structural determination of a glucuronide conjugate of flucytosine in humans.

Chouini-Lalanne N, Malet-Martino MC, Gilard V, Ader JC, Martino R. Chouini-Lalanne N, et al. Among authors: gilard v. Drug Metab Dispos. 1995 Aug;23(8):813-7. Drug Metab Dispos. 1995. PMID: 7493547 Clinical Trial.

4

Chemical and biological evaluation of hydrolysis products of cyclophosphamide.

Gilard V, Martino R, Malet-Martino MC, Kutscher B, Müller A, Niemeyer U, Pohl J, Polymeropoulos EE. Gilard V, et al. J Med Chem. 1994 Nov 11;37(23):3986-93. doi: 10.1021/jm00049a018. J Med Chem. 1994. PMID: 7966159

5

Determination of the urinary excretion of ifosfamide and its phosphorated metabolites by phosphorus-31 nuclear magnetic resonance spectroscopy.

Gilard V, Malet-Martino MC, de Forni M, Niemeyer U, Ader JC, Martino R. Gilard V, et al. Cancer Chemother Pharmacol. 1993;31(5):387-94. doi: 10.1007/BF00686153. Cancer Chemother Pharmacol. 1993. PMID: 8431973

6

Urinary stability of carboxycyclophosphamide and carboxyifosfamide, two major metabolites of the anticancer drugs cyclophosphamide and ifosfamide.

Joqueviel C, Gilard V, Martino R, Malet-Martino M, Niemeyer U. Joqueviel C, et al. Among authors: gilard v. Cancer Chemother Pharmacol. 1997;40(5):391-9. doi: 10.1007/s002800050676. Cancer Chemother Pharmacol. 1997. PMID: 9272115

7

Stability of commercial formulations and aqueous solutions of ifosfamide: a reply.

Gilard V, Martino R, Malet-Martino M, Niemeyer U. Gilard V, et al. Drug Metab Dispos. 1997 Aug;25(8):927-31. Drug Metab Dispos. 1997. PMID: 9280400

8

Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopy.

Joqueviel C, Martino R, Gilard V, Malet-Martino M, Canal P, Niemeyer U. Joqueviel C, et al. Among authors: gilard v. Drug Metab Dispos. 1998 May;26(5):418-28. Drug Metab Dispos. 1998. PMID: 9571223

9

Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors.

Sabatier J, Gilard V, Malet-Martino M, Ranjeva JP, Terral C, Breil S, Delisle MB, Manelfe C, Tremoulet M, Berry I. Sabatier J, et al. Among authors: gilard v. Invest Radiol. 1999 Mar;34(3):230-5. doi: 10.1097/00004424-199903000-00013. Invest Radiol. 1999. PMID: 10084669

10

Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.

Gilard V, Martino R, Malet-Martino M, Niemeyer U, Pohl J. Gilard V, et al. J Med Chem. 1999 Jul 15;42(14):2542-60. doi: 10.1021/jm980587g. J Med Chem. 1999. PMID: 10411475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters